G Medical Innovations Holdings Ltd
Change company Symbol lookup
Select an option...
GMVD G Medical Innovations Holdings Ltd
CMPX Compass Therapeutics Inc.
AMST Amesite Inc
AMPX Amprius Technologies Inc
PRTK Paratek Pharmaceuticals Inc
EGRAY Energy Resources Of Australia Ltd
IVAC Intevac Inc
PFE Pfizer Inc
BNOX Bionomics Ltd
CRKN Crown Electrokinetics Corp.

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Providers & Services | Small Cap Value
Based in Cayman Islands
Company profile

G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.

Closing Price
Day's Change
-0.75 (-45.18%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Nordstrom slashes outlook as holiday sales drop

8:26 am ET January 20, 2023 (MarketWatch)

By Claudia Assis

Holiday sales were 'softer than pre-pandemic,' Nordstrom says

Nordstrom Inc. late Thursday slashed its fiscal 2022 outlook as it offered shoppers more markdowns in the holiday season but still saw a drop in sales.

Nordstrom's (JWN) net sales in the nine weeks ended Dec. 31 fell 3.5% as compared with the year-ago period, the retailer said. That includes a drop in net sales of 1.7% for its flagship Nordstrom stores and a 7.6% drop for Nordstrom Rack stores.

The stock fell more than 6% in the extended session Thursday, after ending the regular trading day down 0.7%.

"The holiday season was highly promotional, and sales were softer than pre-pandemic levels," Chief Executive Erik Nordstrom said.

Nordstrom lowered its fiscal 2022 outlook on per-share earnings to between $1.33 a share and $1.53 a share, compared with a previous outlook of between $2.13 a share and $2.43 a share.

The company called for adjusted EPS of between $1.50 a share and $1.70 a share, compared with a prior guidance of between $2.30 a share and $2.601 a share.

Analysts polled by FactSet expect fiscal 2022 adjusted EPS of $2.35.

"While we continue to see greater resilience in our higher-income cohorts, it is clear that consumers are being more selective with their spending given the broader macro environment," Erik Nordstrom said.

Nordstrom tried to right its inventories by taking addditional markdowns.

It expects inventory levels to be down this year by an unspecified double-digit percentage as compared with last year, and roughly about the same as 2019, it said.

"Having a healthier inventory level and mix positions us well to react quickly to changing consumer demand," said President and Chief Brand Officer Pete Nordstrom.

"Given the continued uncertain environment, we remain focused on executing with flexibility and agility, including conservative buy plans and faster inventory turns," Pete Nordstrom said.

Nordstrom is also "further optimizing" its supply chain to improve the customer experience and expense efficiency, it said. Such initiatives "will continue to deliver significant benefits in 2023," Pete Nordstrom said.

The stock has lost 20% in the past 12 months, compared with losses of around 14% for the S&P 500 index .

Earlier this month, Macy's gave a downbeat forecast for its fourth-quarter sales, with management seeing "lulls" in the holiday season and saying customers likely would feel the squeeze from inflation into next year.

Wall Street has worried that retailers will feel the pinch of rising prices and more reluctant shoppers.

-Claudia Assis


(END) Dow Jones Newswires

January 20, 2023 08:26 ET (13:26 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.